Coronary Microvascular Disease clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Serial PET MPI in Patients Undergoing Cancer Treatment
Sorry, accepting new patients by invitation only
This study aims to evaluate the effects of cardiotoxic cancer therapies on myocardial blood flow (MBF) and perfusion in a prospective sample of VA patients.
Los Angeles 5368361, California 5332921
Our lead scientists for Coronary Microvascular Disease research studies include Rene Packard, MD, PhD.
Last updated: